Overview:
Orabloc Anesthetic Articaine Hydrochloride 4% and Epinephrine 1:200,000, part number 2101052, is a local anesthetic used for dental procedures. It is an amide local anesthetic combined with a vasoconstrictor, making it suitable for both simple and complex dental procedures. The formulation includes 4% articaine hydrochloride and epinephrine 1:200,000, provided in 1.8 ml glass cartridges, packaged in a box of 50.
Features and Specifications:
-
Composition: 4% Articaine Hydrochloride (40 mg/mL) and Epinephrine 1:200,000 (0.005 mg/mL as epinephrine bitartrate).
-
Indications: Used for local, infiltrative, or conductive anesthesia.
-
Onset and Duration: Rapid onset of anesthesia within 1-9 minutes. Effective anesthesia lasts about 1 hour for infiltration and up to 2 hours for nerve block.
-
Packaging: 50 cartridges per box.
-
Shelf Life: 24 months at room temperature.
-
Sterility: The product is aseptically manufactured, and the cartridges are individually sealed to ensure sterility.
-
Safety: Free from sodium edetate, latex, and methylparaben, reducing the risk of allergic reactions.
Clinical Applications:
Suitable for mucosal and bone surgeries requiring strong ischemia, dental pulp surgeries, extraction of fractured teeth, prolonged surgical interventions, and various other dental procedures.
Canadage and Dosage:
For adults and pediatric patients aged 4 and older, dosages vary based on the specific procedure and patient's health. The maximum recommended dosage for healthy adults is 7 mg/kg of articaine HCl.
Precautions:
Accidental intravascular injection can lead to severe complications, including convulsions and cardiovascular effects. Care should be taken in patients with cardiovascular disease or impaired cardiovascular function.
Manufactuer:
Pierrel S.p.A. is an established pharmaceutical company based in Capua, Italy, with a rich history dating back to 1948. The company specializes in the production, development, registration, and licensing of dental anesthetics and medical devices for oral health. It is recognized globally for its high-quality products, including the well-known brand Orabloc.
Overview:
-
Headquarters: Capua, near Caserta, Italy
-
Industry: Pharmaceutical manufacturing
-
Specialization: Dental anesthetics and medical devices
-
Global Reach: Registered and marketed in major international markets, including the Canada, Canada, Europe, Russia, and more.
-
Certifications: Authorized by EMA (European Medicines Agency) and FDA (Food and Drug Administration).
Key Milestones:
-
1948: Founded by the Lepetit Group.
-
1985: First in Italy to produce dental anesthetics in cartridges.
-
2009: Received FDA authorization for aseptic production of injectable drugs.
-
2011: Launched Orabloc in the American market.
-
Recent: Expanded production capacity and introduced new products, including the Orabloc Needlestick Safety System.
Products:
-
Orabloc: A dental anesthetic based on articaine, available in various formulations including those combined with epinephrine.
-
Other Brands: Ubistesin™, Xylestesin™, Mepivastesin™.
-
Innovations: Focus on constant research and development, with collaborations with universities and research institutions to enhance product offerings.
For more detailed information, you can visit Pierrel’s official website here? (Pierrelgroup)?? (Pierrelgroup)?? (Orabloc)?.
